120 related articles for article (PubMed ID: 38327236)
21. Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection.
Yarlagadda V; Samaddar S; Haldar J
J Glob Antimicrob Resist; 2016 Jun; 5():71-4. PubMed ID: 27436471
[TBL] [Abstract][Full Text] [Related]
22. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the Antibacterial Potential of Biosynthesized Silver Nanoparticles Combined with Vancomycin Against Methicillin-Resistant Staphylococcus aureus-Induced Infection in Rats.
Awad M; Yosri M; Abdel-Aziz MM; Younis AM; Sidkey NM
Biol Trace Elem Res; 2021 Nov; 199(11):4225-4236. PubMed ID: 33389618
[TBL] [Abstract][Full Text] [Related]
24. Encapsulation of collagen mimetic peptide-tethered vancomycin liposomes in collagen-based scaffolds for infection control in wounds.
Thapa RK; Kiick KL; Sullivan MO
Acta Biomater; 2020 Feb; 103():115-128. PubMed ID: 31843720
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin-Functionalized Gold and Silver Nanoparticles as an Antibacterial Nanoplatform Against Methicillin-Resistant Staphylococcus aureus.
Hur YE; Park Y
J Nanosci Nanotechnol; 2016 Jun; 16(6):6393-9. PubMed ID: 27427725
[TBL] [Abstract][Full Text] [Related]
26. Antibiofilm and membrane-damaging potential of cuprous oxide nanoparticles against Staphylococcus aureus with reduced susceptibility to vancomycin.
Singh A; Ahmed A; Prasad KN; Khanduja S; Singh SK; Srivastava JK; Gajbhiye NS
Antimicrob Agents Chemother; 2015 Nov; 59(11):6882-90. PubMed ID: 26303796
[TBL] [Abstract][Full Text] [Related]
27. Metal-organic frameworks for on-demand pH controlled delivery of vancomycin from chitosan scaffolds.
Karakeçili A; Topuz B; Korpayev S; Erdek M
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110098. PubMed ID: 31546383
[TBL] [Abstract][Full Text] [Related]
28. "Metaphilic" Cell-Penetrating Polypeptide-Vancomycin Conjugate Efficiently Eradicates Intracellular Bacteria via a Dual Mechanism.
Jiang Y; Han M; Bo Y; Feng Y; Li W; Wu JR; Song Z; Zhao Z; Tan Z; Chen Y; Xue T; Fu Z; Kuo SH; Lau GW; Luijten E; Cheng J
ACS Cent Sci; 2020 Dec; 6(12):2267-2276. PubMed ID: 33376787
[TBL] [Abstract][Full Text] [Related]
29. Bacteria-mimetic nanomedicine for targeted eradication of intracellular MRSA.
Xie B; Zhao H; Zhang R; Ding Y; Gao C; He Y; Wang R
J Control Release; 2023 May; 357():371-378. PubMed ID: 37030543
[TBL] [Abstract][Full Text] [Related]
30. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.
Bose RJC; Tharmalingam N; Choi Y; Madheswaran T; Paulmurugan R; McCarthy JR; Lee SH; Park H
Int J Nanomedicine; 2020; 15():8437-8449. PubMed ID: 33162754
[TBL] [Abstract][Full Text] [Related]
31. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
[TBL] [Abstract][Full Text] [Related]
32. Liposomal delivery of antibiotic loaded nucleic acid nanogels with enhanced drug loading and synergistic anti-inflammatory activity against S. aureus intracellular infections.
Obuobi S; Julin K; Fredheim EGA; Johannessen M; Škalko-Basnet N
J Control Release; 2020 Aug; 324():620-632. PubMed ID: 32525012
[TBL] [Abstract][Full Text] [Related]
33. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide.
Zhang W; Taheri-Ledari R; Hajizadeh Z; Zolfaghari E; Ahghari MR; Maleki A; Hamblin MR; Tian Y
Nanoscale; 2020 Feb; 12(6):3855-3870. PubMed ID: 31996884
[TBL] [Abstract][Full Text] [Related]
34. Supramolecular self-assembled drug delivery system (SADDs) of vancomycin and tocopherol succinate as an antibacterial agent:
Salih M; Omolo CA; Devnarain N; Elrashedy AA; Mocktar C; Soliman MES; Govender T
Pharm Dev Technol; 2020 Nov; 25(9):1090-1108. PubMed ID: 32684052
[TBL] [Abstract][Full Text] [Related]
35. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.
Pei Y; Mohamed MF; Seleem MN; Yeo Y
J Control Release; 2017 Dec; 267():133-143. PubMed ID: 28797580
[TBL] [Abstract][Full Text] [Related]
36. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
[TBL] [Abstract][Full Text] [Related]
37. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.
Andima M; Boese A; Paul P; Koch M; Loretz B; Lehr CM
ACS Infect Dis; 2024 May; 10(5):1696-1710. PubMed ID: 38577780
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen Peroxide-Activated Nitric Oxide-Releasing Vancomycin-Loaded Electrostatic Complexation for Efficient Elimination of Methicillin-Resistant
Chen X; Li W; Jiang X; Fan Q; Li X; Wang L; Li W; Li K; Hong W
Mol Pharm; 2023 Jan; 20(1):711-721. PubMed ID: 36534730
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
Tabuchi F; Matsumoto Y; Ishii M; Tatsuno K; Okazaki M; Sato T; Moriya K; Sekimizu K
J Antibiot (Tokyo); 2017 Jun; 70(6):771-774. PubMed ID: 28196977
[TBL] [Abstract][Full Text] [Related]
40. Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro.
Nguyen AH; Kim S; Maloney WJ; Wenke JC; Yang Y
Antimicrob Agents Chemother; 2012 Jul; 56(7):3776-84. PubMed ID: 22564844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
